Company Overview

iBio, Inc. (NYSE MKT: IBIO), a leader in the plant-made pharmaceutical field, develops and offers pharmaceutical product applications using its iBio Technology platform.

The iBio Technology platform is a proprietary, transformative technology for the production of biologics including monoclonal antibodies, other therapeutic proteins and vaccines.

Upcoming Events

Annual Meeting of Stockholders

Mar 5, 2020 • 9:30am EST

View All Events

Latest Financial Results

Q2 2020

Quarter Ended Dec 31, 2019

Latest Annual Filing

Fiscal Year Ended Jun 30, 2019

View Filing

Stock Information

Leadership

Having accumulated decades of collective experience across a variety of fields, our leadership team is the source of our success.

Investor Contact Information

Company

iBio Inc.
600 Madison Avenue
Suite 1601
New York, NY 10022
T: 302-355-9452
ir@ibioinc.com

Investor Relations

Stephen Kilmer
T: 646-274-3580
skilmer@ibioinc.com

Transfer Agent

Continental Stock Transfer & Trust Company
17 Battery Place
New York, NY 10004
T: 212-509-4000
cstmail@continentalstock.com